Studies have shown that active fund managers routinely underperform the S&P500 index*​

Structure Therapeutics Inc. (NASDAQ: GPCR)

GPCR Stock Predictions and Ratings

WSX Rating:
NOT AVAILABLE
WSX Forecast (1yr):
NOT AVAILABLE
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
197%

GPCR Stock Analysis

GPCR PE Ratio:

GPCR PEG Ratio: Not Available

GPCR Forward EPS Growth (12 month): 0.00%

GPCR PS Ratio:

GPCR PSG Ratio: Not Available

GPCR Forward Revenue Growth (12 month): 0.00%

GPCR Articles

No data was found